MYELODYSPLASIA
Clinical trials for MYELODYSPLASIA explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASIA trials appear
Sign up with your email to follow new studies for MYELODYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Three-Drug cocktail aims to shield cancer patients from dangerous transplant complication
Disease control Recruiting nowThis study is testing whether a combination of three medications given after a stem cell transplant can better prevent severe graft-versus-host disease (GVHD), a serious complication where donor immune cells attack the patient's body. The trial will enroll 124 adults with leukemi…
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: Hannah Choe, MD • Aim: Disease control
Last updated Apr 03, 2026 21:25 UTC
-
Radical transplant trial aims to replace diseased blood systems
Disease control Recruiting nowThis study is testing a specific type of stem cell transplant using donated umbilical cord blood to treat patients with serious blood cancers and disorders. The procedure involves high-dose chemotherapy and radiation to wipe out the patient's diseased bone marrow before infusing …
Matched conditions: MYELODYSPLASIA
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New test could pinpoint cause of mysterious low platelet disorder
Diagnosis Recruiting nowThis study is testing whether a specific lab test that looks for antibodies against a person's own platelets can help doctors diagnose immune thrombocytopenia (ITP) faster and more accurately. It will enroll 225 adults who have been found to have low platelet counts. The goal is …
Matched conditions: MYELODYSPLASIA
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Mar 23, 2026 15:19 UTC